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Introduction
Hepatocellular carcinoma (HCC) is a worldwide problem,
with over 400,000 cases diagnosed in 1990.1 Treatments
include surgical resection, local ablation or even liver trans-
plantation, yet only a minority of patients are suitable for
treatment due to comorbidity, cirrhosis and a shortage of
donor livers. Ablation of HCC offers an attractive alternative
to surgical resection as more hepatic parenchyma is spared,
although many ablative techniques are hampered by pro-
tracted treatment times and an inability to treat large tumours.
A case is hereby presented where a high-risk patient with a
large HCC was treated rapidly and effectively using a novel
microwave applicator.
Case report
A 74-year-old man with known cirrhosis (Childs-Pugh class A)
presented with a history of vague right upper quadrant pain.
Ultrasound and magnetic resonance imaging (MRI) revealed a
tumour measuring 6 cm within the right lobe of the liver. The
tumour’s radiological features in conjunction with a raised
_-fetoprotein (AFP) level of 5,814 Ku/L suggested an HCC,
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which was initially considered to be resectable. Preoperative-
ly, the patient had mild renal and hepatic dysfunction (serum
urea 13.1 mmol/L, creatinine 192 +mol/L, alkaline phos-
phatase 274 IU/L, aspartate aminotransferase 76 IU/L, alanine
aminotransferase 77 IU/L, a-glutamyl-transferase 835 IU/L,
albumin 34.5 g/L, bilirubin 20 +mol/L and international nor-
malized ratio 1.3).
At laparotomy, a large tumour mass was confirmed but
considered inoperable because a formal right hemi-hepatec-
tomy would have been necessary. A newly designed 6.7-mm
diameter microwave applicator (probe) was inserted into the
tumour and a 4-minute, 150 W treatment administered. Ther-
mocouples were placed into the tissue approximately 0.5–1 cm
beyond the tumour margins to ensure that cytotoxic tempera-
tures were achieved. During the microwave treatment, the
patient remained stable and no adverse effects were observed.
Following treatment, the microwave applicator was removed
without haemorrhage. Histology of a biopsy taken at the time
of the procedure confirmed the lesion to be an HCC.
The patient made an uneventful postoperative recovery
with no evidence of a systemic inflammatory response-type
syndrome and AFP levels fell to 55 Ku/L (Figure 1). Six weeks
after surgery, MRI showed that the tumour had been com-
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hepatic inflow occlusion have increased lesion size to approxi-
mately 2 cm in diameter after 10–15 minutes.7 Current micro-
wave treatment of large tumours involves multiple punctures
and repeated treatments in an attempt to ablate the entire
lesion. The new microwave applicator used in this patient is
unique as it can produce large-volume ablations through the
use of newly developed material elements in the emitting
portion of the device.8 The new applicator design was able to
withstand the use of high powers while minimizing reflection
at the tissue/applicator interface. Considerable reflection of
power and heat at the applicator/tissue interface during mi-
crowave treatment, previously thought to be inevitable and
limiting, was greatly reduced with this equipment.9 Moreover,
the large volume of tumour necrosis was achieved in only 4
minutes without complications. This was of crucial importance,
particularly in this high-risk, unstable patient who could not
have withstood a prolonged ablative procedure.
This is the first report of a high-risk patient with a large
HCC within a cirrhotic liver treated with the novel ceramic
microwave applicator. The ability of this system to produce
rapid and complete ablation of such a large tumour marks an
encouraging advance in microwave ablation technology. The
use of a rapid and effective ablation technique such as this is an
attractive option, particularly in unstable high-risk patients
who would not be able to withstand alternative and pro-
longed ablative treatments.
pletely ablated by the microwave treatment. Subsequent scans
1 year and almost 2 years post-treatment showed shrinkage of
the ablated tissue to 5 and 4 cm in diameter, respectively, and
no signs of either tumour recurrence or metachronous lesions
(Figure 2).
Discussion
Only a minority of patients with HCCs can be treated using
surgical resection alone, and the treatment of large lesions
in particular remains a challenge. Many ablative techniques,
from cryotherapy, radiofrequency and microwave ablation
to percutaneous ethanol injection, laser thermotherapy and
focussed ultrasound, are currently being investigated
worldwide. Laser thermotherapy and percutaneous ethanol
injection, for example, have limited use as treatment results
in patients with large tumours are disappointing despite re-
peated treatments.2,3 Radiofrequency ablation has become an
acceptable ablation modality as advances in needle design
have allowed greater ablation volumes to be achieved. Results
in terms of ablation completeness in patients with larger
lesions, however, remain disappointing, with fewer than 50%
completely ablated.4 Cryotherapy has the ability to ablate large
lesions, although the risk of the often fatal cryoshock phe-
nomenon or major haemorrhage increases when larger vol-
umes of tissue are treated.5
Previous microwave applicators have had limited effect in
the treatment of HCCs larger than 2 cm in diameter due to the
small ablation volume produced following a single insertion
of the probe.6 Attempts to increase the ablation volume using
Figure 2. Post-ablation magnetic resonance image showing ablated
region with no evidence of further liver lesions (post-contrast arteri-
al phase).
Figure 1. Reduction in _-fetoprotein (AFP) level post ablation.
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